Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Birch bark extract is a natural extract derived from the bark of birch trees, primarily Betula pendula and Betula pubescens. It is characterized by its rich content of pentacyclic triterpenes, including betulin, betulinic acid, lupeol, erythrodiol, and oleanolic acid. This extract possesses a range of biological activities, such as anti-inflammatory, antibacterial, antiviral, antimycotic, and wound-healing properties. In its pharmaceutical formulation, known as Filsuvez (or Oleogel-S10), it is developed as a topical gel to promote the healing of skin lesions by modulating inflammatory mediators and stimulating the migration and differentiation of keratinocytes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Birch bark extract.